A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes
NCT01469065
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
82
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
PF-04991532
DRUG:
PF-04991532
DRUG:
PF-04991532
DRUG:
PF-0499132
DRUG:
Placebo
Sponsor
Pfizer